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Regulation of endothelin-1 production in cultured rat mesangial
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Regulation of endothelin-1 production in cultured rat mesangial cells.
We investigated the regulatory mechanisms of endothelin (ET)- 1 pro-
duction in cultured rat mesangial cells (MC), with a special focus on the
roles of protein kinase A (PKA)- and protein kinase C (PKC)-mediated
signaling systems. Vasoactive agents and growth promoting factors,
including platelet-derived growth factor, vasopressin and thrombin,
which act through receptors coupled to the phospholipase C-mediated
signaling system, as well as phorbol ester and fetal calf serum stimu-
lated ET-1 production, This effect was attenuated in PKC-depleted or
H-7 (a PKC inhibitor) treated MC. On the other hand, an increase in
intracellular cyclic AMP by forskolin or /3-adrenergic agonist, isopro-
terenol, which act as anti-mitogenic agents, inhibited serum-stimulated
ET-1 production. In addition this effect was mimicked by the addition of
8-bromo-cyclic AMP to the medium. The effect of isoproterenol was
abolished by propranolol. H-8, a PKA inhibitor, attenuated the inhibi-
tory effect of forskolin. These findings suggest that ET-l production in
MC is regulated by interaction of both positive and negative signals
mediated by PKC- and PKA-dependent mechanisms.
We recently reported the production of endothelin (ET)- 1 and
the gene expression of prepro-ET-l mRNA in cultured rat
mesangial cells (MC) [1], but the regulation of this production
remains to be clarified. In endothelial cells (EC), the production
of ET-l is potentiated by several substances, such as Ca2
ionophore, vasoconstricting hormones, and growth promoting
factors [2—5]. Some of these factors act through the receptors
coupled to phospholipase C (PLC). Accordingly, both the
mobilization of intracellular Ca2 and activation of protein
kinase C (PKC) may be involved in the stimulation of ET-l
production. Indeed, phorbol esters, activators of PKC, as well
as Ca2 ionophore cause a marked and immediate stimulation
of ET-l production, accompanied by induction of prepro-ET
mRNA, in human EC [2—4]. Two phorbol ester-responsive
elements are known to locate in the 5'-flanking region of the
human prepro-ET gene [6]. These findings indicate that early
signaling events through the PLC/Ca2/PKC system are in-
volved in the regulation of ET-l production.
Another important cellular signaling system is the adenylate
cyclase (AC)/cyclic AMP (cAMP)/protein kinase A (PKA)
system. Some investigators have shown the inhibition of mito-
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genesis of MC by cAMP [7—10]. Recently, Simonson and Dunn
showed in rat MC that ET activates PLC activity, and that it
also potentiates /3-adrenergic-stimulated cAMP accumulation
[11]. They hypothesized that the AC/cAMP system antagonizes
the PLC/Ca2/PKC system and works as a negative feedback
signal for ET action. Thus, it may be expected that if activation
of the PLC/Ca2/PKC system stimulates ET-1 production in
MC, as in EC, activation of the AC/cAMP/PKA system will
inhibit ET-1 production. The present study was undertaken in
cultured rat MC to examine the regulation of ET- I production
by PKA- and PKC-mediated signaling systems.
Methods
Cell cultures
Cultures of rat mesangial cells were prepared as previously
described [11. For studies of ET-l production, 25 cm2 flasks
(PRIMARIA, Falcon, Lincoln Park, New Jersey, USA) were
used. For studies of double-stranded DNA measurement, cells
were plated on 6-well dishes (Falcon, Lincoln Park, New
Jersey, USA). Subcultured mesangial cells (5 to 15th passage)
were used in the present experiments.
RIA of ET-1
Confluent mesangial cells washed with phosphate buffered
saline (PBS) were preincubated for 48 hours with RPMI 1640 in
the absence of FCS. Subsequently the cells were incubated for
8 or 24 hours with RPMI 1640 that contained FCS as indicated.
Test substances were added in this incubation medium. After
the incubation, media were collected and centrifuged. Then
supernatant was collected and stored at —80°C until measure-
ments were performed. RIA for ET-1 was essentially the same
as previously described [12].
Measurement of double-stranded DNA
The concentration of double stranded DNA was measured by
fluorescence of the complex of mithramycin and double-
stranded DNA (Nuclesan 100, Sanbio, Netherlands) [13]. After
a 48 hour incubation with RPMI 1640, which contained a test
substance or vehicle, the cells were harvested by 0.25% trypsin
and 1.0 mrvi EDTA. The cells were washed twice in PBS and
resuspended in 965 pi of distilled water. After the addition of
pronase the cells were agitated briefly. Then the cells were
incubated for one hour in a gently shaking water bath at 37°C,
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and subsequently they were agitated vigorously for a few
seconds. Samples were placed on ice, then mithramycin was
added, followed by vigorous agitation for at least 10 seconds.
The sample tubes were centrifuged at 5,000 g for 15 minutes to
spin down any undissolved materials. The fluorescence of the
samples was measured using a spectrofluorophotometer
(RF5000, Shimadzu Co., Kyoto, Japan) at an excitation wave-
length of 440 nm and an emission wavelength of 540 nm.
Measurement of [Ca2 7,
Mesangial cells were plated on cover slide and deprived of
FCS for at least 24 hours before the experiments. The cells were
loaded with 2 jM Fura-2 acetoxymethylester (Molecular
Probes, Eugene, Oregon, USA) for 30 minutes. Intracellular
calcium concentration ([Ca2]1) in a single cell was measured by
a computer-assisted Ca2 measurement system (OSP-3, Olym-
pus, Tokyo, Japan); the cells were excited (10 msec) alterna-
tively at 340 and 380 nm, and emmission fluorescence at 510 nm
was measured. At the end of each experiment, the bath was
changed to an ionomycin (10 LM) containing solution (2 mM
Ca2) to measure Rmax, and then to a calcium-free modified
solution containing 1 mrct EGTA and 20 jM ionomycin to
measure Rmjn. [Ca2i was calculated by the following formula:
[Ca2 = Kd([R — Rmin]/{Rmax — R]) X (38OminI38Omax)
where Kd is the dissociation constant of the Fura-2-Ca2
complex (224 nM) [14].
Materials
RPMI 1640 and fetal calf serum (FCS) were obtained from
Gibco Laboratories (Grand Islands, New York, USA). Forsko-
un, phorbol myristate acetate (PMA), isoproterenol, and pro-
pranolol were purchased from Sigma Chemical Co. (St. Louis,
Missouri, USA). N[2-(methylamino)ethyl]-5-isoquinoline-sul-
fonamide (H-8) and 1-(5-isoquinolinylsulfonyl)-2-methylpipera-
zine (H-7) were obtained from Seikagaku Kogyo Co. (Tokyo,
Table 1. Effect of protein kinase C activator, DiC8, on endothelin-1
production
Endothelin-1
pg/mg protein/12 hr
Basal 30.9 5.0
DiC8 lO M 35.3 4.5
iO' M 38.3 6.2a
3 >< !O M 50.0 4.1k
io M 100.3 10.2"
Statistical analysis
All results were expressed as mean SE. The statistical
significance of differences was calculated by the Student's t-test
or variance analysis, and was considered significant when P <
0.05.
Results
Effect of PKC activation on ET-1 production
To examine the role of PKC on ET- 1 production, the effect of
PMA, a direct activator of PKC, was examined. After 48 hours
of serum deprivation, the cells were cultured with 0.5% FCS
medium with or without PMA for 12 hours. ET-1 production
was corrected for cell protein content. As shown in Figure 1,
PMA stimulated the production of ET- 1. PMA at M did
not cause any effect, but iO— or 5 x l0 M PMA significantly
stimulated ET-1 production. Another stimulator of PKC, di-
octanoyl glycerol (DiC8) was also examined. Addition of DiC8
(10 to i0 M) to the medium significantly stimulated the
production of ET-l (Table 1).
We further examined the effect on ET- 1 production of several
substances that are known to act through specific responses
coupled to the PLC-mediated signaling system in mesangial
cells. The tested substances were PDGF (5 U/ml), thrombin (10
U/ml), arginine vasopressin (AVP, iO M), and angiotensin II
(Ang II, i0 M). As shown in Figure 2, each agent except for
Ang II significantly potentiated the production of ET- 1 com-
pared to the control, which was treated with 0.5% FCS alone.
Effects of PMA (l08 M) and 5% FCS are also included in
Figure 2 for comparison. Among these substances, 5% FCS
showed the most potent stimulation of ET-1 production. Since
we could not find the stimulatory effect of Ang II on ET
production, we checked the response of Ang II by measuring
intracellular Ca2 concentration ([Ca2]1). Ang II (lO— M)
induced a spike-shaped Ca2 increase. [Ca2j, increased from
171 15 n to 342 45 nvi (peak value, N 5, P < 0.01).
These results are similar to the values reported by others [15,
16], suggesting that our MC responded to Ang II.
To confirm the importance of PKC-dependent mechanisms in
the stimulation of ET-1 production, the effect of PKC-depletion
was examined. PKC-depletion was made by preincubation with
1
. .
0'••V
WE
Control 10b0
PMA, M
DiC8 is dioctanoyl glycerol.
a P < 0.05 as compared to basal value
b P < 0.01 as compared to basal value
Japan). lonomycin and dioctanoyl glycerol (DiC8) were pur-
chased from Calbiochem-Behring Corp. (La Jolla, California,
USA). Cell protein was measured by a dye-binding method
5 x i09 (Bio-Rad, Richmond, California, USA) using bovine serum
albumin as a standard.
Fig. 1. Effect of PMA on ET-1 production. Serum-depleted mesangial
cells were incubated with PMA (10_to to 5 x l0 M) or 0.5% FCS alone
(Cont) for 12 hours. p < 0.05; ** < 0.01 compared to Cont.
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a high dose of PMA (10- M) for 24 hours. Then, the medium
was removed, and a new culture medium which contained 5%
FCS was added. Figure 3 shows that the ET-l production by
PKC-depleted cells was not increased by the addition of 5%
FCS, which significantly stimulate ET- I production under the
normal condition. Contribution of PKC-dependent mechanisms
was also examined by using PKC inhibitor, H-7. H-7 (l0— to
i0 M) significantly inhibited the PMA-stimulated ET-1 pro-
duction (Table 2). These findings suggest that the stimulation of
ET- 1 production is dependent on PKC.
Effect of cAMP on ET-1 production and mitogenesis
First, the effect of forskolin, a substance that stimulates AC
by bypassing physiological receptors [17—19], on ET-l produc-
tion was examined. Forskolin dose-dependently inhibited the
serum-stimulated (5% FCS) production of ET-l in an eight hour
culture. Forskolin 20 M inhibited ET-l production by 67%
compared to FCS alone (Fig. 4A). The ET-l production cor-
rected for cell protein content was significantly inhibited, and
therefore these findings indicate the inhibition of ET- 1 produc-
tion in each cell. Mitogenesis (as assessed by the content of
double-stranded DNA) of MC, incubated in a 5% FCS-contain-
ing medium for 48 hours, was also attenuated by forskolin. In
the presence of 20 iM forskolin, FCS-stimulated increase in
double-strand DNA was inhibited by 60% (Fig. 4B). 8Br-cAMP
(10—s M) added to the culture medium mimicked the forskolin
effect in terms of ET- 1 production and mitogenesis (data not
shown), implying that the inhibition of ET-1 production by
forskolin is mediated by cAMP.
Next we examined the effect of the receptor-mediated intra-
cellular accumulation of cAMP on ET-1 production. We used a
/3-adrenergic agonist, isoproterenol, which is known to stimu-
late AC in mesangial cells [7, 8, 201. As shown in Figure SA,
isoproterenol (jØ5 to i0 NI) dose-dependently inhibited the
I iiui
PMA 10-8 M 165.5 14.0
+ H-7 iO M 93.4 ll.2a
+ H-7 i0 M 55.9 lola
PMA is phorbol myristate acetate H-7, l-(5-isoquinolinyisulfonyl)-2-
methylpiperazine
a P < 0.01 as compared to PMA (10-8 M) alone
serum-stimulated ET-l production. This inhibitory effect was
antagonized by propranolol, an antagonist of f3-adrenergic
receptors (Fig. SB). Propranolol (10—s M) was added five
minutes prior to the exposure to isoproterenol (10 M). Ac-
cordingly, these findings suggest that isoproterenol affects ET-1
production via /3-adrenergic receptor.
To determine whether the effect of cAMP is mediated by
PKA, H-8, a relatively specific inhibitor of PKA [211, was used.
As shown in Figure 6, 50 LM H-8 itself had little effect on the
FCS (5%)-stimulated ET-1 production, whereas H-8 signifi-
cantly prevented the inhibition of ET-1 production by 20 LM
forskolin (115 14 vs. 42 14 pg!mg protein/8 hr). This finding
suggests that cAMP inhibits serum-stimulated ET- I production
at least partly by PKA-dependent mechanism(s).
Discussion
In the present study, we suggest that the production of ET-1
is potentiated by activation of PKC, whereas it was attenuated
by activation of PKA in rat MC. To our knowledge, this is the
first report of the inhibition of ET-1 production in ET-l-
producing cells.
In cultured rat MC, our data showed that receptor-mediated
PLC-activating agents, including thrombin, AVP, and PDGF,
but not Ang II, significantly potentiate ET-l production (Fig. 3).
I
C'1
LU
300 —
200
100
0
uJ.
Fig. 2. Effect of various agents on ET-1 production. The effect of
individual agents on ET-1 production was compared with that of 0.5%
FCS alone (Cont). The concentration of each agent was as follows
PDGF 5 U/mi, thrombin 10 U/mI, AVP iO M, PMA 108 M and FCS
5%. Abbreviations are in the text. *P < 0.05; 8P < 0.01; 88P < 0.001.
PKCdeptetion (—) (—) (+) (+)
FCS (—) (+) (—) (+)
Fig. 3. Effect of FCS on ET-1 production in the mesangial cells with or
without PKC depletion. To deplete PKC, mesangial cells were prein-
cubated with i0 M PMA for 24 hours. *p < 0.01 compared to FCS-
and PKC depletion-free.
Table 2. Effect of protein kinase C inhibitor, H-7, on endotheiin-1
production induced by PMA
Endothelin-1
pg/mg protein/12 hr
Sakamoto et a!: ET-1 production in cultured mesangial cells 353
160
A
200
160
120
80
40
0
B
FOR, M
B
16
Control i07 106 i05
ISO, M
A
240
200
C120
0_
- Q)
C
0
FOR
Fig. 4. Effect of forskolin on serum-stimulated ET-1 production and
mitogenesis. A. Dose-response of forskolin (FOR) to serum-stimulated
ET-1 production. The ET-l concentration of conditioned medium was
measured 8 hours after addition of the agent in the presence of 5% FCS.
B. Effect of forskolin (20 tM) on mitogenesis stimulated by 5% FCS for
48 hours. Mitogenesis was assessed as the content of double stranded
DNA. Control (Cont) indicates the content of double-stranded DNA in
the cells cultured in the absence of FCS. *D < 0.05; < 0.01
compared to Controls.
Previous studies have also demonstrated that these agents
stimulate ET-l production in endothelial [2, 4] and non-endo-
thelial cells, such as vascular smooth muscle cells [22]and renal
tubular cells [23]. Since the common feature of these agents is
their action on the receptors coupled to PLC, both the mobili-
zation of intracellular Ca2 and activation of PKC may be
closely involved in the stimulation of ET-l production. This
view is supported by the findings that phorbol esters and Ca2
C .
+-o.
L
-c:
C
o
Fig. 5. Effect of isoproterenol (ISO) on serum-stimulated ET-1 produc-
tion. A. Dose-response of isoproterenol to serum (5% FCS)-stimulated
ET-1 production. B. Effect of propranolol (PRO; i0- M) on the
inhibition of ET-1 production by isoproterenol (10—s M). Propranolol
was added 5 minutes prior to the exposure to isoproterenol. Control
(Cont) indicates the ET- 1 production in the cells cultured with 5% FCS
alone. < 0.05; < 0.01 compared to Cont.
ionophore cause an induction of prepro-ET mRNA and a
marked and immediate stimulation of ET production in human
endothelial cells [2, 3, 6]. Our results in rat MC that PMA and
DiC8 stimulate ET-l production, and that the stimulation of
ET-l production is abolished in the PKC-depleted or H-7
treated cells also support this thesis. In the presence of low
dose serum, the effects of PMA and DiC8 were evident, but
they were not seen in the total absence of serum, suggesting
that cofactor(s) such as competence factor in serum is neces-
sary for PKC-induced endothelin production.
Ang II, however, did not stimulate the ET-l production in
+
Control ISO ISO
+
PRO
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cultured rat MC, despite that this substance is known to act
through a receptor coupled to PLC [24]. Interestingly, Ganz,
Perfetto and Boron recently showed that Ang II can produce a
typical transient increase in cell Ca2, but it does not cause cell
proliferation in rat cultured MC [25]. In their study, other
agonists, such as AVP and PDGF can stimulate MC prolifera-
tion with concomitant increase in cell Ca2 and stimulation of
the phosphoinositide cascade. Therefore, these results taken
together may imply that another signaling pathway(s) activated
by Ang II inhibits ET production.
Contrary to the stimulatory effect of the PLC/Ca2/PKC
system on ET- 1 production, we showed that either an increase
in intracellular cAMP or the administration of exogenous cAMP
inhibited serum-stimulated ET- 1 production in cultured rat MC
(Fig. 4). This is the first demonstration of an inhibitory factor on
ET-1 production. Since the effect of cAMP on ET-1 production
was abolished by H-8, cAMP may act at least partly through a
PKA-dependent mechanism(s). However, interpretation of the
data may need some caution since H-8 is not a pure specific
inhibitor of PKA, and the dose we used (50 p.M) was high,
therefore it may cause non-specific effects. The cellular mech-
anisms of PKA on ET-1 production are not clear at present.
Among the possibilities, the effect of PKA on transcription of
the ET-1 gene is interesting, and this should be evaluated in
future studies.
A f3-adrenergic agonist, isoproterenol, inhibited serum-stim-
ulated ET-l production, and this effect was abolished by
3-adrenergic antagonist, propranolol (Fig. 5). These effects may
be due to an accumulation of cAMP caused by the stimulation
of AC by isoproterenol [7, 8, 20]. The physiologic implication of
this finding is that ET-1 production in MC is neurologically
regulated by the signals through 3-adrenergic receptor. Re-
cently, Simmonson and Dunn demonstrated that exogenously
administered ET-1 potentiates f3-adrenergic-stimulated intracel-
lular cAMP accumulation in addition to increasing the intracellular
Ca2 concentration [11] and hydrolyzing of inositol phosphates
[26]. Since an increase in intracellular cAMP concentration
could potentially dampen cell contraction caused by activation
of the Ca2IPKC signaling system [261, they speculated that the
cAMP-dependent signaling pathway may act as a negative
feedback signal in the regulation of MC functions. Our present
study may further expand this thesis regarding ET-l produc-
tion. Exogenous application of ET-l to MC activates PLC-
mediated signaling systems [26], and activation of the systems
stimulates ET-l production. Thus, the net effect would be an
autonomous increase in ET-l production. Therefore, negative
feedback signals are needed to regulate ET-l production. The
cAMP/PKA system may play this role, since exogenous ET-l
addition also amplifies cAMP production if /3-adrenergic stim-
ulus is present [11]. Thus, ET-l production in MC may be
adequately regulated by the interaction of both positive and
negative signals mediated by PKC- and PKA-dependent mech-
anisms.
The physiological role(s) of ET-l in MC is not clear at
present, but two possibilities are suspected: First, ET-l may
work as an autocrine growth factor for MC. MC are known to
produce several growth factors, such as interleukin-l [27, 281,
PDGF [291, and insulin-like growth factor [30, 311, and these
substances stimulate mitogenesis of their own cells in an
autocrine fashion. ET-l has also been shown to stimulate
mitogenesis in MC [26, 32]. Accordingly, ET-1 may play some
role in the proliferation of MC, especially in glomerulonephritis.
Second, ET- 1 may work as a constrictor of MC and contribute
to the regulation of glomerular filtration rate. Therefore, precise
regulation of ET- 1 production in MC may be important in
normal and pathophysiological states.
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